Entering text into the input field will update the search result below

Merck's Keytruda approved as adjuvant therapy for stage IIb, IIc melanoma

Dec. 03, 2021 4:55 PM ETMerck & Co., Inc. (MRK) StockBy: Jonathan Block, SA News Editor1 Comment

Merck Canada head office in Kirkland, Quebec, Canada.

JHVEPhoto/iStock Editorial via Getty Images

Recommended For You

About MRK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MRK--
Merck & Co., Inc.